| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Journal of Applied Physiology, Vol 78, Issue 6 2039-2046, Copyright © 1995 by American Physiological Society
ARTICLES |
S. Chemtob, P. Hardy, D. Abran, D. Y. Li, K. Peri, O. Cuzzani and D. R. Varma
Department of Pediatrics, University of Montreal, Quebec, Canada.
To test the role of reactive oxygen species and cyclooxygenase products in the retinal hemodynamic changes induced by asphyxia, we measured retinal (RBF) and choroidal blood flows (ChBF), malondialdehyde (MDA), prostaglandin E2 (PGE2), 6-ketoprostaglandin F1 alpha (6-keto-PGF1 alpha), and thromboxane B2 (TxB2) in 1- to 3-day-old pigs treated with saline, the free radical scavengers U-74389F or high-dose allopurinol, the cyclooxygenase inhibitors ibuprofen or indomethacin, or the thromboxane synthase blocker CGS-13080 before and 5 and 60 min after a 5-min period of asphyxia. In saline-treated animals, RBF and ChBF increased 5 min after asphyxia and decreased at 60 min. The increases in RBF and ChBF at 5 min postasphyxia were slightly attenuated by cyclooxygenase blockers and free radical scavengers but not by thromboxane synthase inhibition, whereas all drugs prevented the decreases at 60 min. MDA, TxB2, PGE2, and 6-keto-PGF1 alpha increased 5 min after asphyxia; at 60 min, PGE2 and 6-keto-PGF1 alpha returned to nearly preasphyxial levels, but MDA and TxB2 continued to increase. Cyclooxygenase inhibition prevented the asphyxia-induced rise in MDA, and the free radical scavengers prevented that of prostanoids. In isolated eyecup preparations, H2O2 and cumene hydroperoxide constricted retinal arteries; this effect was blocked by cyclooxygenase and thromboxane synthase inhibitors. The data suggest that during oxidative stresses reactive oxygen species are generated from the cyclooxygenase pathway and, in turn, also activate the synthesis of thromboxane; the latter mediates the oxidative stress-induced ocular vasoconstriction that might trigger the neovascularization of retinopathy of prematurity.
This article has been cited by other articles:
|
|
 |
|
  C. Quiniou, F. Sennlaub, M. H. Beauchamp, D. Checchin, I. Lahaie, S. Brault, F. Gobeil Jr., M. Sirinyan, A. Kooli, P. Hardy, et al. Dominant Role for Calpain in Thromboxane-Induced Neuromicrovascular Endothelial Cytotoxicity J. Pharmacol. Exp. Ther., February 1, 2006; 316(2): 618 - 627. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. H. Beauchamp, A. M. Marrache, X. Hou, F. Gobeil Jr, S. G. Bernier, P. Lachapelle, D. Abran, C. Quiniou, S. Brault, K. G. Peri, et al. Platelet-Activating Factor in Vasoobliteration of Oxygen-Induced Retinopathy Invest. Ophthalmol. Vis. Sci., October 1, 2002; 43(10): 3327 - 3337. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. H. Wright, D. Abran, M. Bhattacharya, X. Hou, S. G. Bernier, A. Bouayad, J.-C. Fouron, A. Vazquez-Tello, M. H. Beauchamp, R. I. Clyman, et al. Prostanoid receptors: ontogeny and implications in vascular physiology Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2001; 281(5): R1343 - R1360. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Hou, L. J. Roberts II, D. F. Taber, J. D. Morrow, K. Kanai, F. Gobeil Jr., M. H. Beauchamp, S. G. Bernier, G. Lepage, D. R. Varma, et al. 2,3-Dinor-5,6-dihydro-15-F2t-isoprostane: a bioactive prostanoid metabolite Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2001; 281(2): R391 - R400. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. H. Beauchamp, A. K. Martinez-Bermudez, F. Gobeil Jr., A. M. Marrache, X. Hou, G. Speranza, D. Abran, C. Quiniou, P. Lachapelle, J. Roberts II, et al. Role of thromboxane in retinal microvascular degeneration in oxygen-induced retinopathy J Appl Physiol, June 1, 2001; 90(6): 2279 - 2288. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. F. E. Nilsson, O. Mäepea, A. Alm, and K. Narfström Ocular Blood Flow and Retinal Metabolism in Abyssinian Cats with Hereditary Retinal Degeneration Invest. Ophthalmol. Vis. Sci., April 1, 2001; 42(5): 1038 - 1044. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. Hardy, I. Dumont, M. Bhattacharya, X. Hou, P. Lachapelle, D. R. Varma, and S. Chemtob Oxidants, nitric oxide and prostanoids in the developing ocular vasculature: a basis for ischemic retinopathy Cardiovasc Res, August 18, 2000; 47(3): 489 - 509. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Najarian, P. Hardy, X. Hou, J. Lachapelle, A. Doke, F. Gobeil Jr., M.-S. Roy, P. Lachapelle, D. R. Varma, and S. Chemtob Preservation of neural function in the perinate by high PGE2 levels acting via EP2 receptors J Appl Physiol, August 1, 2000; 89(2): 777 - 784. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Hou, F. Gobeil Jr, K. Peri, G. Speranza, A. M. Marrache, P. Lachapelle, J. Roberts II, D. R. Varma, S. Chemtob, and E. F. Ellis Augmented Vasoconstriction and Thromboxane Formation by 15-F2t-Isoprostane (8-Iso-Prostaglandin F2{alpha}) in Immature Pig Periventricular Brain Microvessels • Editorial Comment Stroke, February 1, 2000; 31(2): 516 - 524. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Dumont, K. G. Peri, P. Hardy, X. Hou, A. K. Martinez-Bermudez, S. Molotchnikoff, D. R. Varma, and S. Chemtob PGE2, via EP3 receptors, regulates brain nitric oxide synthase in the perinatal period Am J Physiol Regulatory Integrative Comp Physiol, December 1, 1998; 275(6): R1812 - R1821. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Lahaie, P. Hardy, X. Hou, H. Hassessian, P. Asselin, P. Lachapelle, G. Almazan, D. R. Varma, J. D. Morrow, L. J. Roberts II, et al. A novel mechanism for vasoconstrictor action of 8-isoprostaglandin F2alpha on retinal vessels Am J Physiol Regulatory Integrative Comp Physiol, May 1, 1998; 274(5): R1406 - R1416. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
